Shear Stress Insensitivity of Endothelial Nitric Oxide Synthase Expression as a Genetic Risk Factor for Coronary Heart Disease

Coronary heart disease (CHD) is based on the development of atherosclerosis in coronary arteries. Shear stress-induced endothelial nitric oxide (NO) release not only contributes to local blood pressure control but also effectively helps to retard atherosclerosis. Therefore, functionally relevant polymorphisms in the endothelial NO synthase (NOS-3) gene may contribute to the development of CHD. NOS-3 expression was analyzed in endothelial cells isolated from umbilical cords genotyped for the −786C/T single nucleotide polymorphism (SNP) of the human nos-3 gene. Moreover, NO-dependent relaxation was examined in segments of saphenous vein isolated from genotyped patients undergoing aortocoronary bypass surgery, and patients subjected to quantitative coronary angiography were genotyped to verify an association between this SNP and CHD. Shear stress-induced NOS-3 mRNA and protein expression was present in TT and CT genotype cells but absent in cells with CC genotype. Pretreatment of these cells with a decoy oligonucleotide comprising position −800 to −779 of the C-type nos-3 promoter reconstituted shear stress-induced NOS-3 expression. These results were confirmed by reporter gene analysis with the corresponding nos-3 promoter luciferase constructs. In addition, the NO-mediated relaxant response of vein grafts from CC genotype patients was significantly attenuated as compared with the CT or TT genotype, and in CHD-positive patients, the CC genotype was significantly more frequent (19.0%) than in CHD-negative patients (4.4%). The −786C/T SNP of the nos-3 gene thus constitutes a genetic risk factor for CHD, presumably due to binding of an inhibitory transcription factor to the C-type promoter blocking shear stress-dependent maintenance of NOS-3 expression.

[1]  Xin Chen,et al.  TRANSFAC: an integrated system for gene expression regulation , 2000, Nucleic Acids Res..

[2]  K. Channon,et al.  Vascular superoxide production by NAD(P)H oxidase: association with endothelial dysfunction and clinical risk factors. , 2000, Circulation research.

[3]  M. Biondi,et al.  Independent risk factor for moderate to severe internal carotid artery stenosis: T786C mutation of the endothelial nitric oxide synthase gene. , 2002, Clinical chemistry.

[4]  E. Lonn,et al.  The T-786→C Mutation in Endothelial Nitric Oxide Synthase Is Associated With Hypertension , 2002, Hypertension.

[5]  T. Nakayama,et al.  Association of a variable number of tandem repeats in the endothelial constitutive nitric oxide synthase gene with essential hypertension in Japanese. , 1998, American journal of hypertension.

[6]  J. Loscalzo.  Nitric oxide insufficiency, platelet activation, and arterial thrombosis. , 2001, Circulation research.

[7]  L. Ignarro.  Endothelium‐derived nitric oxide: actions and properties , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  A. Hingorani,et al.  Genetic and Environmental Determinants of Plasma Nitrogen Oxides and Risk of Ischemic Heart Disease , 2001, Hypertension.

[9]  A. Pries,et al.  Design principles of vascular beds. , 1995, Circulation research.

[10]  V. Álvarez,et al.  Association between the NOS3 (-786 T/C) and the ACE (I/D) DNA genotypes and early coronary artery disease. , 2001, Nitric oxide : biology and chemistry.

[11]  KazuwaNakao,et al.  T−786→C Mutation in the 5′-Flanking Region of the Endothelial Nitric Oxide Synthase Gene Is Associated With Coronary Spasm , 1999 .

[12]  N. Lynch,et al.  Differential Expression of the Murine Mannose-Binding Lectins A and C in Lymphoid and Nonlymphoid Organs and Tissues 1 , 2003, The Journal of Immunology.

[13]  Christian Webel,et al.  Decoy oligodeoxynucleotide againstactivator protein-1 reducesneointimal proliferation after coronaryangioplasty in hypercholesterolemic minipigs , 2002 .

[14]  M. Hecker,et al.  Shear Stress–Dependent Regulation of the Human &bgr;-Tubulin Folding Cofactor D Gene , 2000, Circulation research.

[15]  G. Garcı́a-Cardeña,et al.  Endothelial Dysfunction, Hemodynamic Forces, and Atherogenesis a , 2000, Annals of the New York Academy of Sciences.

[16]  A. Hingorani,et al.  A common variant of the endothelial nitric oxide synthase (Glu298-->Asp) is a major risk factor for coronary artery disease in the UK. , 1999, Circulation.

[17]  A. Pessina,et al.  The T-786C endothelial nitric oxide synthase genotype is a novel risk factor for coronary artery disease in Caucasian patients of the GENICA study. , 2003, Journal of the American College of Cardiology.

[18]  M. Hecker,et al.  Interleukin-10 Induction of Nitric-oxide Synthase Expression Attenuates CD40-mediated Interleukin-12 Synthesis in Human Endothelial Cells* , 2003, Journal of Biological Chemistry.

[19]  P. Scheurich,et al.  A permissive role for tumor necrosis factor in vascular endothelial growth factor-induced vascular permeability. , 2001, Blood.

[20]  Herrmann,et al.  Polymorphisms of the endothelial nitric oxide synthase gene — no consistent association with myocardial infarction in the ECTIM study , 1999, European journal of clinical investigation.

[21]  R. Nerem,et al.  Phosphorylation of endothelial nitric oxide synthase in response to fluid shear stress. , 1996, Circulation research.

[22]  K. Nakao,et al.  T(-786)--> C mutation in the 5'-flanking region of the endothelial nitric oxide synthase gene is associated with myocardial infarction, especially without coronary organic stenosis. , 2000, The American journal of cardiology.

[23]  G. Hardy.  MENDELIAN PROPORTIONS IN A MIXED POPULATION. , 1908 .

[24]  P. Ganz,et al.  Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. , 1986, The New England journal of medicine.

[25]  J. Moss,et al.  Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[26]  U. Förstermann,et al.  Expressional control of the ‘constitutive’ isoforms of nitric oxide synthase (NOS I and NOS III) , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[27]  Christian Webel,et al.  Decoy oligodeoxynucleotide against activator protein-1 reduces neointimal proliferation after coronary angioplasty in hypercholesterolemic minipigs. , 2002, Journal of the American College of Cardiology.

[28]  S. Masetti,et al.  Endothelial nitric oxide synthase gene polymorphisms and risk of coronary artery disease. , 2003, Clinical chemistry.

[29]  K. Nakao,et al.  T-786-->C mutation in the 5'-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. , 1999, Circulation.

[30]  A. Bruschke,et al.  The Anatomic Evolution of Coronary Artery Disease Demonstrated by Coronary Arteriography in 256 Nonoperated Patients , 1981, Circulation.

[31]  K. Kangawa,et al.  Replication protein A1 reduces transcription of the endothelial nitric oxide synthase gene containing a -786T-->C mutation associated with coronary spastic angina. , 2000, Human molecular genetics.